These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3867660)

  • 1. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Meulemans A
    J Antimicrob Chemother; 1985 Dec; 16(6):751-5. PubMed ID: 3867660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections.
    Jacobs RF; Kearns GL; Brown AL; Longee DC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):670-4. PubMed ID: 3458427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin.
    Rodriguez K; Dickinson GM; Greenman RL
    South Med J; 1985 Jun; 78(6):731-2. PubMed ID: 3859018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Antimicrob Agents Chemother; 1983 Jul; 24(1):126-8. PubMed ID: 6354077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerability of imipenem/cilastatin in infections at various sites].
    Grassi C; Baglioni A; Bonsignore G; Catena E; De Rose V; Grignani F; Lotti T; Orlandi O; Panichi G; Pavone Macaluso M
    G Ital Chemioter; 1986; 33(2-3):143-8. PubMed ID: 3479372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Imipenem/cilastatin in surgical intensive medicine].
    Wenk H; Schier H; Hollandt H; Valesky A
    Infection; 1986; 14 Suppl 2():S171-5. PubMed ID: 3759252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
    Naber KG; Adam D; Bauernfeind A; Hönig E
    Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal penetration of N-formimidoyl thienamycin in normal rabbits: potentiation by coadministration of renal dipeptidase enzyme inhibitor.
    Chow AW; Finlay KR; Stiver HG; Carlson CL
    Antimicrob Agents Chemother; 1983 Apr; 23(4):634-6. PubMed ID: 6574725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
    Wang C; Pappas F; Cook T
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dosage of imipenem/cilastatin].
    Shah PM
    Infection; 1986; 14 Suppl 2():S143-7. PubMed ID: 3759249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.